Apyx Medical Corporation APYX Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Apyx Medical Corporation's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
- Apyx Medical Corporation (APYX) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$54K in Q1 2026.
- How has Apyx Medical Corporation's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
- Apyx Medical Corporation's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 2800.0% year-over-year, from $2K to -$54K.